CLRB Competitors & Alternatives
Compare Cellectar Biosciences Inc with similar stocks in the same industry
Biotechnology
CLRB
Main Stock$2.66
Tradestie Score
42
Market Cap
$18.42M
Analyst Upside
+332.3%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.60
|
$154.27M | - | 61 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.81
|
$133.50M | - | 54 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.29
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.27
|
$110.20M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.30
|
$71.69M | - | 49 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.42
|
$67.94M | - | 52 | Compare |
|
MBRX
Moleculin Biotech, Inc.
|
$0.43
|
$26.23M | - | 47 | Compare |
|
PULM
Pulmatrix, Inc. Common Stock
|
$1.74
|
$17.88M | - | 48 | Compare |
|
BLRX
BioLineRX Ltd
|
$2.66
|
$16.50M | - | 48 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
More CLRB Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry